Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy

被引:90
|
作者
Biteker, Murat [1 ]
Ilhan, Erkan [2 ]
Biteker, Gul [3 ]
Duman, Dursun [1 ]
Bozkurt, Biykem [4 ,5 ]
机构
[1] Haydarpasa Numune Educ & Res Hosp, Dept Cardiol, Istanbul, Turkey
[2] Siyami Ersek Cardiovasc Surg Ctr, Dept Cardiol, Istanbul, Turkey
[3] Ortaca Yucelen Hosp, Dept Obstet & Gynecol, Istanbul, Turkey
[4] Baylor Coll Med, Dept Med, Cardiol Sect, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
[5] Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA
关键词
Peripartum cardiomyopathy; Late recovery; Treatment; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREDICTORS; PROGNOSIS; SOCIETY; HEART;
D O I
10.1093/eurjhf/hfs070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Persistence of left ventricular (LV) systolic dysfunction after 6 months of diagnosis is believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy (PPCM). We sought to determine the length of time required for recovery of LV systolic function (LVSF) in patients with PPCM. Forty-two consecutive women with PPCM were enrolled in this prospective study. The minimum required time of follow-up for inclusion was 30 months. Each patient underwent transthoracic echocardiography, and plasma brain natriuretic peptide (BNP) and C-reactive protein measurement at admission, and every 3 months. Early recovery was defined as normalization of LVSF at 6 months post-diagnosis. Delayed recovery was defined if the length of time required for recovery of LVSF was longer than 6 months. Persistent left ventricular dysfunction (PLVD) was defined as an ejection fraction of 50 at the end of follow-up. Twenty patients (47.6) recovered completely, 10 died (23.8), and 12 (28.6) had PLVD. Average time to complete recovery was 19.3 months after initial diagnosis (342 months). Early recovery was observed only in six patients (30), whereas delayed recovery was observed in 14 out of 20 patients (70). Patients with complete recovery were more likely to have a higher LV ejection fraction and smaller LV end-systolic dimensions at baseline. Full recovery of LVSF in PPCM patients often requires longer than 6 months.
引用
收藏
页码:895 / 901
页数:7
相关论文
共 50 条
  • [1] Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy
    Biteker, M.
    Ilhan, E.
    Duman, D.
    Can, M.
    Dayan, A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 638 - 638
  • [2] Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy
    Biteker, M.
    Ilhan, E.
    Duman, D.
    Can, M.
    Dayan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 638 - 638
  • [3] Delayed Rocovery in Peripartum Cardiomyopathy: An Indication for Long-Term Follow-Up and Sustained Therapy
    Biteker, Murat
    Ilhan, Erkan
    Duman, Dursun
    Can, Mehmet M.
    Tekke, Ahmet
    CIRCULATION, 2011, 124 (21)
  • [4] Delayed Mortality in Peripartum Cardiomyopathy Indicates Need for Long-Term Follow-Up
    Gollapudi, Kranti
    Forster, Olaf
    Libhaber, Elena
    Tibazarwa, Kemi
    Tshani, Winnie
    Sliwa, Karen
    CIRCULATION, 2008, 118 (18) : S1029 - S1029
  • [5] Delayed mortality in peripartum cardiomyopathy indicates need for long-term follow up
    Sliwa, K.
    Forster, O.
    Tibazarwa, K.
    Libhaber, E.
    Becker, A.
    Yip, A.
    Hilfiker-Kleiner, D.
    EUROPEAN HEART JOURNAL, 2009, 30 : 447 - 447
  • [6] Peripartum cardiomyopathy - risk factors, characteristics and long-term follow-up
    Shani, Hagit
    Kuperstein, Rafael
    Berlin, Alla
    Arad, Michael
    Goldenberg, Ilan
    Simchen, Michal J.
    JOURNAL OF PERINATAL MEDICINE, 2015, 43 (01) : 95 - 101
  • [7] Long-term follow-up study of sustained biochemical responders with interferon therapy
    Shindo, M
    Hamada, K
    Oda, Y
    Okuno, T
    HEPATOLOGY, 2001, 33 (05) : 1299 - 1302
  • [8] Long-term follow-up of patients with hypertrophic cardiomyopathy
    Arteaga, E
    Ianni, BM
    Fernandes, F
    Wajsbrot, DB
    Mady, C
    CIRCULATION, 1999, 100 (18) : 77 - 77
  • [9] METOPROLOL IN DILATED CARDIOMYOPATHY - LONG-TERM FOLLOW-UP
    ENGELMEIER, R
    OCONNELL, J
    RAD, N
    WALSH, R
    SCANLON, P
    GUNNAR, R
    CIRCULATION, 1986, 74 (04) : 309 - 309
  • [10] LONG-TERM FOLLOW-UP IN HYPERTROPHIC CARDIOMYOPATHY - MEDICAL VERSUS SURGICAL THERAPY
    SEILER, C
    HESS, OM
    TURINA, J
    SCHOENBECK, M
    JENNI, R
    ROTHLIN, M
    SENNING, A
    TURINA, M
    KRAYENBUHL, HP
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 119 (43) : 1511 - 1514